BioCentury | Nov 26, 2020
Product Development

U.S. government spending on Abbott BinaxNOW outstrips other rapid COVID-19 tests: Data Byte

...August , Abbott said it had shipped 7 million ID NOW tests.The COVID-19 molecular test from Cue Health Inc....
...for predicting who is most likely to spread SARS-CoV-2. Karen Tkach Tuzman Abbott Laboratories Quidel Corp. Becton Dickinson and Co. Cue Health Inc. cov19dx rapid...
BioCentury | Jun 15, 2020
Product Development

NCATS seeks to create hub for COVID-19 data; Regeneron reports preclinical data backing antiviral mAb cocktail

...COVID-19 Treatment Trial as well as investigator-initiated COVID-19 studies of the rheumatoid arthritis drug. Meanwhile, Cue Health Inc....
...LY3009104 (Compound #), INCB28050 (Former compound #), baricitinib (Generic), Olumiant (Other) NIH Regeneron Pharmaceuticals Inc. Eli Lilly and Co. Cue Health Inc. Almac...
BioCentury | Jun 12, 2020
Finance

June 11 Quick Takes: Biotech swept up in sell-off; plus Simcere, Lantern, Cue Health, C2i, BaseLaunch, Sanofi-Cathay and 4BIO

...the drug repurposing company’s proposed range. Cue Health raises $100M for COVID-19 test Diagnostics company Cue Health Inc....
...Tokyo:4151) made an undisclosed investment in the firm’s second therapeutics-focused fund. BioCentury Staff Simcere Pharmaceutical Group Lantern Pharma Inc. Cue Health Inc. Pureos...
BioCentury | Jul 13, 2018
Financial News

Cue Health raises $45M series B

...Development Authority (BARDA) to develop diagnostics for respiratory pathogens and influenza. Cue Health Inc., San Diego, Calif. Alicia Parker Cue Health Inc....
Items per page:
1 - 4 of 4
BioCentury | Nov 26, 2020
Product Development

U.S. government spending on Abbott BinaxNOW outstrips other rapid COVID-19 tests: Data Byte

...August , Abbott said it had shipped 7 million ID NOW tests.The COVID-19 molecular test from Cue Health Inc....
...for predicting who is most likely to spread SARS-CoV-2. Karen Tkach Tuzman Abbott Laboratories Quidel Corp. Becton Dickinson and Co. Cue Health Inc. cov19dx rapid...
BioCentury | Jun 15, 2020
Product Development

NCATS seeks to create hub for COVID-19 data; Regeneron reports preclinical data backing antiviral mAb cocktail

...COVID-19 Treatment Trial as well as investigator-initiated COVID-19 studies of the rheumatoid arthritis drug. Meanwhile, Cue Health Inc....
...LY3009104 (Compound #), INCB28050 (Former compound #), baricitinib (Generic), Olumiant (Other) NIH Regeneron Pharmaceuticals Inc. Eli Lilly and Co. Cue Health Inc. Almac...
BioCentury | Jun 12, 2020
Finance

June 11 Quick Takes: Biotech swept up in sell-off; plus Simcere, Lantern, Cue Health, C2i, BaseLaunch, Sanofi-Cathay and 4BIO

...the drug repurposing company’s proposed range. Cue Health raises $100M for COVID-19 test Diagnostics company Cue Health Inc....
...Tokyo:4151) made an undisclosed investment in the firm’s second therapeutics-focused fund. BioCentury Staff Simcere Pharmaceutical Group Lantern Pharma Inc. Cue Health Inc. Pureos...
BioCentury | Jul 13, 2018
Financial News

Cue Health raises $45M series B

...Development Authority (BARDA) to develop diagnostics for respiratory pathogens and influenza. Cue Health Inc., San Diego, Calif. Alicia Parker Cue Health Inc....
Items per page:
1 - 4 of 4